Defining the Optimal Neoadjuvant Treatment Strategy in Patients with Resectable Pancreas Cancer Xiang, M., Chang, D. T., Heestand, M., Pollom, E. ELSEVIER SCIENCE INC. 2019: E249

View details for DOI 10.1016/j.ijrobp.2019.06.1939

View details for Web of Science ID 000485671500568